Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metformin+Sitagliptin”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03115112
What this trial is testing

Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes Mellitus
Theracos 386
Large-scale testing (Phase 3)Study completedNCT01106677
What this trial is testing

The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 1,284
Large-scale testing (Phase 3)Study completedNCT06952231
What this trial is testing

Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
University of Lahore 50
Large-scale testing (Phase 3)Study completedNCT02532855
What this trial is testing

Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 614
Testing effectiveness (Phase 2)Study completedNCT01169090
What this trial is testing

A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy

Who this might be right for
Type 2 Diabetes
Kowa Research Institute, Inc. 620
Post-approval studies (Phase 4)Study completedNCT02147925
What this trial is testing

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Sun Yat-sen University 75
Testing effectiveness (Phase 2)Study completedNCT01475461
What this trial is testing

Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 345
Post-approval studies (Phase 4)Study completedNCT02941445
What this trial is testing

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Who this might be right for
Polycystic Ovary SyndromeBody Weight
University Medical Centre Ljubljana 24
Large-scale testing (Phase 3)Study completedNCT00541775
What this trial is testing

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 273
Post-approval studies (Phase 4)UnknownNCT01717911
What this trial is testing

SS-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia

Who this might be right for
Type 2 Diabetes
Taipei Veterans General Hospital, Taiwan 160
Large-scale testing (Phase 3)Study completedNCT00683735
What this trial is testing

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

Who this might be right for
Diabetes
Michael A. Nauck 20
Post-approval studies (Phase 4)Ended earlyNCT02373865
What this trial is testing

Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
GWT-TUD GmbH 4
Not applicableStudy completedNCT00806520
What this trial is testing

Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control

Who this might be right for
Type 2 Diabetes
HealthPartners Institute 16
Early research (Phase 1)Study completedNCT07567781
What this trial is testing

Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

Who this might be right for
Healthy Volunteers
AbbVie 12
Testing effectiveness (Phase 2)Study completedNCT01336322
What this trial is testing

Metformin and Sitagliptin in Women With Previous Gestational Diabetes

Who this might be right for
Pre-diabetes
University of Pisa 40
Early research (Phase 1)Study completedNCT06124573
What this trial is testing

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Who this might be right for
BioequivalenceDiabetes Mellitus, Type 2
Galenicum Health 48
Early research (Phase 1)Study completedNCT06124547
What this trial is testing

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.

Who this might be right for
BioequivalenceDiabetes Mellitus, Type 2
Galenicum Health 48
Large-scale testing (Phase 3)Study completedNCT00086515
What this trial is testing

Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

Who this might be right for
Diabetes Mellitus, Type II
Merck Sharp & Dohme LLC 701
Early research (Phase 1)Study completedNCT05798715
What this trial is testing

Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)

Who this might be right for
Healthy
Genuine Research Center, Egypt 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT07365358
What this trial is testing

Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabete Type 2
Chong Kun Dang Pharmaceutical 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation